Mingchen Health Co., Ltd. Class A

Mingchen Health Co., Ltd. Class A

SSZSE:002919
17.04
CNY
+1.13
(+7.10%)
0.02EPS
556.74P/E
5.05BMarket Cap
Oct 30Next Earn
Mingchen Health Co., Ltd. Class A
SZSE:002919
(Shenzhen Stock Exchange)

Recent

price

17.04

P/E

ratio

556.74

div

yld

0.32%

ROIC.AI

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
2.27
2.1
3.13
2.99
3.19
2.02
1.95
2.56
2.79
3.41
6.05
5.18
5.68
6.35
Revenue per Share
0.11
0.12
0.23
0.24
0.24
0.11
0.09
0.38
0.5
0.09
0.26
0.18
0.11
0.03
Basic EPS, GAAP
0.22
0.05
0.54
0.36
-0.18
-0.03
0.08
0.59
0.24
-0.28
0.21
0.44
- -
- -
Free Cash Flow per Basic Share
0.01
0.01
- -
- -
0.08
0.06
0.03
0.06
0.12
0.13
- -
0.12
0.05
0.06
Dividend per Share
0.79
0.96
1.15
1.44
2.02
2.06
2.12
2.46
2.84
2.77
3.04
3.09
3.03
2.96
Book Value per Share
0.76
0.93
1.12
1.41
1.99
2.04
2.1
1.96
2.37
1.27
2.09
2.13
1.67
1.63
Tangible Book Value per Share
188
267
188
199
201
270
265
266
267
277
271
267
267
265
Basic Weighted Avg Shares
426
559
588
596
642
546
517
681
744
945
1,638
1,380
1,514
1,682
Sales/Revenue/Turnover
5.82
6.81
9.18
8.47
8.39
5.49
4.79
16.6
16.05
-1.35
6.2
7.29
1.45
-1.27
Operating Margin (%)
9
8
8
8
9
9
9
12
24
50
175
47
24
- -
Depreciation Expense
21
32
44
47
49
30
23
102
133
25
70
47
28
9
Net Income, GAAP
12.38
12.78
14.68
14.72
13.23
13.05
11.91
2.41
- -
- -
- -
- -
48.16
78.05
Effective Tax Rate (%)
4.91
5.68
7.4
7.95
7.56
5.43
4.46
15.02
17.94
2.69
4.3
3.38
1.87
0.54
Profit Margin (%)
71
99
149
210
463
472
479
438
479
196
421
425
300
285
Working Capital
- -
- -
- -
- -
- -
- -
- -
24
19
59
26
13
21
16
LT Debt
149
180
230
287
538
551
565
655
758
740
810
823
807
786
Total Equity
- -
14.17
19.24
17.47
11.61
5.04
4.23
15.94
- -
- -
- -
- -
3.54
0.74
Return on Invested Capital (%)
- -
17.24
20.1
18.14
11.66
5.25
4.14
16.2
- -
- -
- -
- -
3.37
1.45
Return on Capital (%)
- -
19.32
21.2
18.33
11.76
5.45
4.14
16.75
18.89
3.39
9.08
5.72
3.47
1.11
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
90
92
62
LT Borrowings
- -
- -
- -
LT Finance Leases
21
18
16
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
267
267
266
Market Capitalization
6,127
5,261
5,054

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
733
727
687
Cash, Cash Equivalents & STI
350
349
322
Accounts Receivable, Net
215
196
174
Inventories
72
76
75
Total Current Liabilities
433
420
402
Payables & Accruals
- -
- -
- -
ST Debt
90
92
62
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
15.54%
4.47%
-2%
Free Cash Flow
-43.6%
-89.04%
-99.02%
Net Income, GAAP
34.7%
10.75%
-39.41%
Sales/Revenue/Turnover
12.41%
20.72%
9.72%
Total Cash Common Dividend
- -
- -
-58.57%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
362
303
320
396
1,380
2025
361
350
- -
436
1,514
2026
418
478
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.17
0.06
0.14
-0.19
0.18
2025
0.05
0.11
- -
-0.05
0.11
2026
0.03
-0.05
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.12
2025
- -
- -
- -
- -
0.05
2026
- -
0.05
- -
- -
- -
Business
Mingchen Health Co., Ltd. (002919.SZ) develops, produces and sells personal health care products principally in China; its core offerings include skin care products, shampoos, conditioners, shower gels, hair styling gels and related daily chemical items under brands such as Dihua Zhixiu, DIFASO, SunShine Fruit Oil, Mei Wang, First Collection, Golden Lion, Likoujian, High Tech Health, Green Effect, Yicai, Xiao Qiqi and Fice. The company also operates an online gaming segment providing digital entertainment services. Founded in 1994 and headquartered in Shantou, China, Mingchen Health primarily targets domestic consumer markets in the household and personal products industry with approximately 1,267 employees. In recent developments, the company completed a share repurchase program in July 2025, acquiring 1.86 million shares for RMB 31 million at prices between RMB 15.9 and RMB 17.1 per share to enhance shareholder value; it reported first-half 2025 revenue of RMB 712 million, up 7% year-over-year, alongside third-quarter results showing nine-month revenue growth of 9.6% to RMB 1.08 billion despite profit declines amid cost-efficiency initiatives and mini-program game expansions.